Praxis Precision Medicines
IPOHome - Praxis Medicines
Public · United States · $110.0M raised
- Business Model
- B2B
- Website
- praxismedicines.com
- Total Funding
- $110.0M
- Last Round
- $110.0M Series CMay 2020
- Rounds
- 1
- Type
- Public
About
Clinical-stage biopharmaceutical company translating insights from genetic epilepsies into therapies for broader neurological conditions.
Summary
Praxis Precision Medicines is a Biotech company based in United States. It has raised $110.0M in total across 1 round, most recently a $110.0M Series C round in May 2020. Investors include Eventide Asset Management, Vida Ventures and OCV Partners.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2020
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...